We have previously shown that the presence of trophoblast cells enhances invasiveness of decidualizing human endometrial stromal cells. The metastasis suppressor CD82, which has antimigratory function in tumor cells, is up-regulated in decidualizing endometrial stromal cells. CEACAM1 is expressed in trophoblast cells at the invasion front in early placenta and is considered proinvasive. Here, we investigate the role of CD82 and CEACAM1 in cocultures of the endometrial stromal cell line T-HESC and AC-1M88 trophoblast cells. In transwell migration assays, chemotaxis of AC-1M88 cells was stimulated by coplated T-HESC in the lower compartment or by the combination of heparin-binding EGF-like growth factor (HB-EGF), interleukin-1 beta (IL-1beta), and leukemia inhibitory factor (LIF), local factors present at the time of implantation. In an implantation model of AC-1M88 trophoblast spheroids on a monolayer of T-HESC, spheroid expansion was enhanced in the presence of HB-EGF/IL-1beta/LIF. Silencing of CEACAM1 in AC-1M88 blunted this response. Chemotactic migration of T-HESC was stimulated by trophoblast secretions or HB-EGF/IL-1beta/LIF. These responses were suppressed by CD82 depletion in T-HESC. Proteome profiling revealed the presence of platelet-derived growth factor (PDGF)-AA in trophoblast supernatant. Chemotaxis of T-HESC toward PDGF-AA was significantly inhibited by CD82 silencing. Neutralization of PDGF-AA in AC-1M88 conditioned media reduced the chemotactic effect on T-HESC. In summary, we demonstrate a mutual stimulation of chemotactic migration between trophoblast and endometrial stromal cells and promigratory roles for the cell surface molecules CEACAM1 and CD82, which may serve to support tissue remodeling at the implantation site.
INTRODUCTION
Blastocyst implantation in humans involves intimate interactions between trophoblast cells and decidualizing stromal cells of the maternal endometrium. As opposed to other mammals, decidualization of the stromal compartment in humans is not triggered by the blastocyst but is a maternally driven differentiation process that becomes apparent in the midsecretory phase of the menstrual cycle. In the event of pregnancy, decidualized endometrial stromal cells are harnessed for the challenges associated with implantation and placentation. They have acquired the ability to resist inflammatory and oxidative stress signals and to dampen local immune responses to the invading trophoblast [1] . Recent evidence suggests that they are also capable of responding to developmentally impaired embryos and may thus serve as biosensors for embryo quality [2] . While the processes of implantation and placentation have been widely viewed as an intrusion of the highly invasive trophoblast into a passive decidual matrix, this concept has been challenged recently. Evidence is accumulating that successful implantation also depends on the ability of decidualizing endometrial stromal cells to migrate and actively encapsulate the embryo [3] [4] [5] . Decidualization renders endometrial stromal cells more responsive to trophoblast-derived signals and enhances their motility and invasiveness. Moreover, decidualized cells provide a favorable matrix for trophoblast expansion [6, 7] .
The events at the implantation site display characteristics of an inflammatory reaction, and elevation of proinflammatory cytokines/chemokines in the endometrium promotes acquisition of uterine receptivity [8] . The proinflammatory cytokine leukemia inhibitory factor (LIF) was the first cytokine shown to be critical for implantation in mice [9] . Its pattern of expression also suggests a role in human implantation, the major source being endometrial epithelial cells [10] . In pregnancy, LIF and its receptor LIF-R are detected in the decidua, and LIF-R is found in villous and extravillous trophoblast [11] . Interleukin-1 beta (IL-1b) is a proinflammatory cytokine that is maximally expressed in the endometrium during the late secretory phase. Its receptor IL-1R-1 is present in endometrial stromal cells of the mid-to late secretory phase. In early pregnancy, IL-1b is abundant and localizes to the decidua, villous cytotrophoblast, and syncytiotrophoblast [11] . Endometrial secretion cytokine profiling in in vitro fertilization cycles immediately prior to embryo transfer indicated a predictive value of IL-1b levels for clinical pregnancy [12] .
Heparin-binding EGF-like growth factor (HB-EGF) is an important mediator between the receptive endometrium and the implanting blastocyst [13, 14] . HB-EGF levels are highest in the receptive phase endometrium. HB-EGF promotes decidualization of endometrial stromal cells and, in pregnancy, extravillous differentiation of trophoblast cells along the invasive pathway [13, 15, 16] .
In previous studies, we observed regulation of the tetraspanin CD82 (Tspan-27; formerly also known as KAI1) in decidualizing endometrial stromal cells and of carcinoembryonic antigenrelated cell adhesion molecule-1 (CEACAM1) in invasive trophoblast cells by HB-EGF, IL-1b, and LIF [7, 17] . In the present study, we set out to further investigate the roles of these cell-specific cell surface molecules that might participate in decidual-trophoblast communication and mutual regulation of motile responses. At the feto-maternal interface, the tetraspanin CD82 is specifically expressed on decidualized endometrial stromal cells [17] . CD82 has initially been characterized as a metastasis suppressor in numerous malignancies because loss of its expression correlates with enhanced metastasizing potential of a given tumor [18, 19] . Several mechanisms have been proposed to underlie the metastasis suppressor activity. For one, CD82 engages in lateral interactions with other plasma membrane molecules, such as the epidermal growth factor receptor (EGFR; c-ErbB-1), cadherin-1 (E-cadherin), integrins, or other tetraspanins and negatively impacts motility, invasiveness, and adhesion of various cell types [20] [21] [22] . Furthermore, CD82 has been demonstrated to interact with the Duffy antigen/chemokine receptor, which is expressed on endothelial cells. Thus, CD82-expressing cancer cells, having intravasated blood or lymphatic vessels, attach to the endothelial wall via Duffy and receive a senescent signal, leading to their elimination [23, 24] . While we have observed that decidualization coincides with increased CD82 protein expression in human endometrial stromal cells (hESCs), the functional consequences are unclear [17] . A recent study implicated reduced CD82 expression of endometriotic hESCs in the pathogenesis of the disease because silencing of CD82 in hESCs enhanced their invasiveness [25] .
CEACAM1, a member of the immunoglobulin superfamily, is found at the invasion front of extravillous trophoblast cells (EVT) disseminating from the tips of anchoring villi [26] . Presence of CEACAM1 in melanomas is associated with poor prognosis, and overexpression in melanoma cells promotes invasiveness. CEACAM1 levels are elevated on transfection of integrin b 3 in this cell type [27] . Apart from this report, little is known about the regulation of CEACAM1. We observed an induction of CEACAM1 protein in the trophoblast cell line AC-1M88 on treatment with a combination of HB-EGF, LIF, and IL-1b. Simultaneously, these factors promoted the expansion of AC-1M88 spheroids cultured on a monolayer of hESCs in an in vitro implantation model [7] . Conversely, CD82 in hESCs was modestly induced by HB-EGF and strongly by IL-1b alone or in combination with LIF [7, 17] .
Thus, both CEACAM1 and CD82 show partly concordant patterns of regulation, are functionally interconnected with integrins, play roles in the modulation of motility and invasiveness, and are present at the implantation site. We therefore set out to investigate the function of CEACAM1 in trophoblast and of CD82 in endometrial stromal cells in intercellular communication using coculture models and migration assays.
MATERIALS AND METHODS

Growth Factors, Cytokines, and Hormones
Human recombinant HB-EGF, LIF, hepatocyte growth factor (HGF), insulin, medroxyprogesterone acetate (MPA), and 17b-estradiol (E2) were from Sigma-Aldrich (Deisenhofen, Germany), IL-1b and IL-6 from Miltenyi Biotec (Bergisch Gladbach, Germany), platelet-derived growth factor (PDGF)-AA from Peprotech (Hamburg, Germany), and placenta growth factor isoform 1 (PlGF-1) from Biomol (Hamburg, Germany). Neutralizing antibody to PDGF (goat polyclonal, recognizing PDGF-AA,-AB,-BB) was from R&D Systems (Abingdon, U.K.) and used at 50 lg/ml.
Cell Culture
The telomerase-immortalized human endometrial stromal line T-HESC was obtained from American Type Culture Collection (Manassas, VA; ATCC No. CRL-4003) [28] . Cells were maintained in ESC medium: phenol red-free Dulbecco modified Eagle medium (DMEM)/Hams F12 (F12) with 10% steroid-depleted dialyzed fetal bovine serum (FCS; PromoCell, Heidelberg, Germany), 100 U/ml penicillin, and 100 lg/ml streptomycin, supplemented with insulin (1 lg/ml) and E2 (1 nM). Decidualization was induced in minimal medium 1 (MM1; ESC medium without insulin and E2) in the presence of 0.5 mM 8-Br-cAMP (Biolog, Bremen, Germany) in combination with 1 lM MPA over a period of 5 days, unless indicated otherwise. Decidualization was confirmed by measurement of prolactin (PRL) and insulin-like growth factorbinding protein 1 (IGFBP-1) in the supernatants (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org). Conditioned medium from undifferentiated and decidualized T-HESC was prepared as follows. Confluent cells in MM1 were left untreated or treated with 8-BrcAMP/MPA for 5 days, washed, and incubated in fresh MM1 without stimuli for 24 h before supernatants were harvested and added directly to trophoblast cell cultures. The decidualization stimulus had to be omitted for the last 24 h because cAMP analog had proven detrimental to the trophoblast cell line.
The invasive trophoblast cell line AC-1M88, a fusion of primary EVT from term placenta with a selectable mutant of the JEG-3 choriocarcinoma cell line [29] [30] [31] , was maintained in DMEM/F12 with 10% complete FCS, 100 U/ml penicillin, and 100 lg/ml streptomycin.
siRNA Transfection
Stealth Select RNAi siRNAs, targeting CD82 or CEACAM1 (sets of three siRNAs each), were purchased from Invitrogen (Darmstadt, Germany) and are designated si-CD82 and si-CEACAM1 hereafter. As a negative control (si-neg), Scrambled Stealth RNAi siRNA duplex was used (Invitrogen). Confluent T-HESC in six-well plates, in 2 ml serum-free medium (Opti-MEM; Invitrogen), were transfected with 150 pMol si-CD82 or si-neg per well and mixed with 5 ll Lipofectamine 2000 (Invitrogen) in 500 ll Opti-MEM. The transfection mix was left on the cells overnight before initiation of decidualizing treatment. AC-1M88 cells were transfected with si-CEACAM1 or si-neg using the same protocol, but the transfection mix was removed after 6 h. For spheroid formation, transfected cells were trypsinized at this time point and replated as described below. If to be used for transwell migration assays, transfected cells received fresh medium and were plated in the transwell inserts 2 days later.
Formation of Trophoblast Spheroids
Spheroids from trophoblast cells were formed on the basis of a procedure described by Korff et al. [32] . For preparation of 100 spheroids, 3 3 10 5 AC-1M88 cells were suspended in 9.11 ml of medium and mixed with 890 ll of a 2.8% methylcellulose solution (R&D Systems, Wiesbaden, Germany). Per well of a nonadherent round-bottom 96-well plate (Greiner Bio-One, Frickenhausen, Germany), 100 ll of this suspension containing 3000 cells were plated and incubated at 378C in 5% CO 2 . Twenty-four hours later, spheroids had formed and were used for the spheroid expansion assay as detailed below.
Spheroid Expansion Assay
The expansion of trophoblast spheroids plated on cell culture surface or on a monolayer of T-HESC was assayed essentially as described previously [7] . Briefly, T-HESC were left untreated or were predecidualized for 5 days either with 8-Br-cAMP alone or with 8-Br-cAMP/MPA. Decidualized cells were plated at a density of 8 3 10 4 cells/500 ll MM1 and undifferentiated cells at 4.5 3 10 4 cells/500 ll MM1 in eight-well chamber slides (BD Biosciences, Heidelberg, Germany). On the same day, spheroid formation was initiated. After 24 h, stimuli were diluted into 500 ll MM1 and added to the chamber slides carrying T-HESC or to empty chamber slides. At this time, AC-1M88 spheroids had formed and were transferred in 20 ll media onto the T-HESC monolayers or directly into eight-well-chamber slides without T-HESC using one spheroid per well. Phase contrast microphotographs were taken immediately with a digital camera on an inverted microscope. This time point was designated d0. The decidualization stimulus was omitted during the coculture phase because 8-Br-cAMP is toxic for AC-1M88 cells. On d2 or d3, media were aspirated, cells were fixed with 4% paraformaldehyde for 5 min at room temperature and washed with PBS and subjected to dual immunocytochemistry for vimentin (marker of stromal cells) and cytokeratin-7 (marker of trophoblast cells) as previously described [7] . Stained spheroids were photographed. The areas covered by spheroids at d0, and at d2 or d3, were determined with the ImageJ software (http://rsb.info.nih.gov/ij), and the fold expansion of each individual spheroid over 2 or 3 days was calculated. Each treatment was done on six to eight replicate wells, and experiments were repeated at least three times.
To evaluate the effect of CD82 silencing on spheroid expansion, T-HESC were transfected with si-neg or si-CD82 siRNAs the day before initiation of the decidualizing treatment. To control for the efficiency and duration of silencing, aliquots of the cells plated for the spheroid expansion assay were seeded in sixwell plates and harvested in RIPA buffer (10 mM Tris-HCl pH 7.4, 150 mM GELLERSEN ET AL. NaCl, 1 mM EDTA, 1% Triton-X100, 1% sodium deoxycholate, 0.1% SDS) in parallel with the termination of the expansion assay, that is, 2 or 3 days later. CD82 expression was monitored by Western blot analysis. Conversely, the effect of CEACAM1 silencing on spheroid expansion was addressed by transfecting AC-1M88 cells with si-neg or si-CEACAM1 siRNAs 6 h prior to initiation of spheroid formation. When the transfected cells were collected for spheroid formation, again an aliquot was plated per well in six-well plates for Western blot control of silencing. RIPA extracts were prepared at the time point when the spheroid expansion assay was terminated and analyzed by immunoblotting for CEACAM1. Alternatively, spheroids from AC-1M88 cells transfected with si-neg or si-CEACAM1 were plated for spheroid expansion assays, and silencing controls were performed by plating spheroids in parallel for protein extraction: 20 spheroids were placed per six wells and subjected to the same stimulations as the spheroids in the expansion assay, and RIPA extracts were harvested in parallel with termination of the expansion assay.
Transwell Migration Assay for Chemotaxis
Chemotactic migration assays were performed in cell culture inserts with 8-lm pores in 24-well recipient plates (BD Biosciences). The inserts received T-HESC or AC-1M88 cells. T-HESC, either nondecidualized or predecidualized by 5 days of treatment with 8-Br-cAMP/MPA, were plated at a density of 3 3 10 4 cells per insert in 300 ll Opti-MEM. AC-1M88 were plated at 2 3 10 4 cells per insert in 300 ll Opti-MEM. The recipient wells received 750 ll MM1 without or with added growth factors and cytokines. Migration was terminated after 24 h by fixation and staining with Diff-Quik (Siemens Health Care Diagnostics, Eschborn, Germany). Each treatment was done in quadruplicate wells. From three inserts, the nonmigrated cells on the upper side of the membrane were removed with a cotton swab as in the conventional transwell migration procedure. From the fourth insert, migrated cells were removed from the lower side of the membrane. On each membrane, cells were counted in six randomly selected fields (103 objective), and the mean number of cells per visual field (N) was determined. The number of cells on the upper side (N U ), derived from the fourth insert, was added to the mean of three inserts counted on the lower side (N L ), yielding the total number of cells per visual field (N T ). The motility index was determined as the percentage of migrated cells relative to the total cell number (N L /N T 3 100). This procedure of normalization was chosen to correct for putative differences in cell numbers, possibly due to different proliferation rates, when different cell populations were compared (e.g., nondecidualized versus decidualized or nontransfected versus transfected cells, in the absence or presence of growth factors).
For indirect coculture experiments, T-HESC or AC-1M88 cells were plated into the 24-well bottom recipient wells 24 h before initiation of the transwell migration assay at a density of 3 3 10 5 cells in 1 ml MM1. The conditioned medium was removed after 24 h and replaced by 750 ll of fresh MM1 when cells were added to the migration inserts on top. In other instances, 750 ll of 24-h conditioned medium from AC-1M88 cells were added as a chemoattractant to the lower compartment in T-HESC migration assays. Further, the 24-h conditioned medium from T-HESC or AC-1M88 cells was used for stimulation of monolayer cultures before harvesting RIPA extracts.
Wound Healing Assay for Chemokinesis
As a modification of the established wound healing or scratch assay, we set up an Ibidi migration assay by placing two-well cell culture inserts (Ibidi GmbH, Munich, Germany) into four-well chamber slides (BD Biosciences), using two culture inserts per well. Per well of the cell culture inserts, 70 ll MM1 containing 8 3 10 3 T-HESC were added. The inserts were carefully lifted after 23 h, leaving two cell-free gaps, similar to those created by scratching for wound healing assay, per well of the chamber slide. Wells received 700 ll MM1, including motogenic stimuli, and the gaps were photographed to monitor the original distance between the opposite cell fronts. Cells were allowed to migrate into the cell-free zone for 18 h and were then fixed and stained with Diff-Quik. Gaps were again photographed with a 43 objective in three partially overlapping neighboring areas to cover the entire width of the gap. Images of the gaps were reassembled and numbers of migrated cells determined by counting nuclei with the Fiji software (http://fiji.sc/wiki/index.php/Fiji). In brief, the images were converted to 16-bit gray scale. The threshold was adjusted until the stained nuclei were highlighted as separate particles, and the particle number was counted after appropriately setting minimum and maximum particle sizes and degree of circularity.
Proteome Profiling
For preparation of conditioned media, AC-1M88 cells, undifferentiated T-HESC, or predecidualized T-HESC (5-day treatment with 8-Br-cAMP/MPA) were suspended in MM1-2% (MM1 with only 2% steroid-depleted FCS) and plated at a density of 1.2 3 10 6 cells per well in six-well plates. The next day, medium was replaced by 1.2 ml fresh MM1-2% and the supernatant harvested 24 h later. Aliquots were stored at À808C for proteome analysis. Proteome Profiler Array Kits (Human Cytokine Array Panel A or Human Angiogenesis Array; R&D Systems) were applied according to the manufacturer's instructions, using 1 ml of conditioned medium per membrane. The cytokine array membrane carries capture antibodies to 36, the angiogenesis array membrane to 55 factors, each spotted in duplicate. Samples were mixed with a cocktail of biotinylated detection antibodies, allowed to bind to the membranes, and detected with streptavidin-HRP and chemiluminescence reagent. After exposure to film, signal intensities were quantified using ImageJ software. Integrated densities of each spot were corrected for background signal and normalized to positive control spots contained on each membrane. After graphical plotting in Excel, the X-axis was split into three sections and values within the lower, middle, or upper third of the range were classified as weak (þ), medium (þþ), or strong (þþþ) signals, respectively.
Western Blotting
Whole cell extracts were prepared in RIPA buffer and subjected to SDS-PAGE as detailed previously [7] . CD82 was detected under nonreducing conditions (clone TS82b, 1:500; Diaclone, Besançon, France). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; clone 6C5, 1:10000; HyTest, Turku, Finland) and EGFR (clone D38B1, 1:5000; Cell Signaling Technology, Danvers, MA) were detected under nonreducing or reducing conditions. Two different rabbit monoclonal antibodies to HER4 (c-ErbB4) were employed under reducing conditions (clone E200, 1:5000; Epitomics, Burlingame, CA; and clone 111B2, 1:1000; Cell Signaling Technology). CEACAM1 was detected under reducing conditions (clone 4D1C2, 0.5 lg/ml) [26] .
For short-term stimulations, cells were plated in 12-well plates using 4 3 10 5 cells per well and serum-starved overnight in Opti-MEM. The next day, cells were stimulated for 5, 10, or 30 min in Opti-MEM and directly extracted into gel loading buffer preheated to 858C (50 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 0.1% bromophenol blue, 5% b-mercaptoethanol). For detection of CD82 on Western blots with these quick extracts, an antibody was used that detects CD82 under reducing conditions (G-2, 1:200; Santa Cruz Biotechnology, Heidelberg, Germany).
Statistical Analysis
Data were analyzed by ANOVA followed by Tukey or Dunnett post hoc test, using GraphPad Prism 5 (GraphPad Software, San Diego, CA). Unless indicated otherwise, figures reflect representative experiments performed in replicates as detailed above, and each experiment was repeated a minimum of three times.
RESULTS
Silencing of CEACAM1 in Trophoblast Spheroids Reduces Their Expansion on an Endometrial Stromal Cell Monolayer
We previously observed in an in vitro implantation model that AC-1M88 trophoblast spheroids expanded to a greater extent on a monolayer of decidualized hESCs than on undifferentiated hESCs. Furthermore, expansion on undifferentiated cells was enhanced by the addition of HB-EGF/IL-1b/ LIF given in combination, and this coincided with an increase in CEACAM1 protein expression in the trophoblast cells [7] . We now assessed the effect of each factor individually. Trophoblast spheroids were placed on a monolayer of undifferentiated T-HESC in the absence or presence of the above factors given alone or in dual or triple combinations (Fig. 1) . LIF alone had no effect on trophoblast expansion. IL1b or HB-EGF alone and all combinations containing either factor stimulated spheroid spreading. In protein extracts from AC-1M88 cells, CEACAM1 was elevated on HB-EGF treatment, and this was augmented by the addition of either LIF or IL-1b. The most pronounced induction of CEACAM1 was seen with the triple combination HB-EGF/IL-1b/LIF. In essence, there was no direct correlation between the degree of spheroid expansion and the level of CEACAM1.
As a next step, we asked whether the presence of CEACAM1 in trophoblast cells was required for spheroid expansion. To this ROLE OF CD82 AND CEACAM1 IN IMPLANTATION end, spheroids in which CEACAM1 had been silenced by transfection of si-CEACAM1 were compared to spheroids transfected with a scrambled control siRNA (si-neg; Fig. 2 ). When plated in the absence of a stromal monolayer, spheroids expanded about 20-fold within 3 days. This was enhanced by the addition of HB-EGF/IL-1b/LIF; however, silencing of CEA-CAM1 had no effect. As expected, spheroid expansion was more pronounced (about 40-fold) on T-HESC monolayer and further stimulated by the factor combination. The strongest expansion was observed on decidualized T-HESC plus HB-EGF/IL-1b/LIF, using control-transfected trophoblast cells. While silencing of CEACAM1 had no effect on spreading in the absence of factors, factor-stimulated spreading on T-HESC monolayers was significantly inhibited on si-CEACAM1 transfection (Fig. 2A) . The efficiency and persistence of CEACAM1 silencing over the entire period of the expansion assay was confirmed by Western blotting on protein extracts from transfected spheroids (Fig. 2B) . HB-EGF is known to bind to homo-or heterodimers of EGFR (c-ErbB1) and HER4 (c-ErbB4) [33] . In control-transfected spheroids, EGFR was down-regulated on treatment with HB-EGF/IL-1b/ LIF. Interestingly, silencing of CEACAM1 prevented EGFR down-regulation by the factor cocktail (Fig. 2B) . HER4 was not detectable in AC-1M88 cells (data not shown).
Silencing of CD82 in the Underlying Endometrial Stromal Cell Monolayer Does Not Affect Expansion of Cocultured Trophoblast Spheroids
In other cell systems, CD82 has been characterized as an antimigratory and anti-invasive cell surface molecule, in line with its initial identification as a metastasis suppressor. On the other hand, in previous spheroid expansion experiments, decidualizing hESCs expressing higher levels of CD82 had supported trophoblast spreading more so than had undifferentiated hESCs, which have little or no CD82 [7] . To address this phenomenon, spheroid expansion assays were performed with T-HESC in which CD82 had been silenced by RNA interference. In detail, T-HESC were transfected with si-neg or si-CD82 and then induced to decidualize over 5 days with cAMP alone or with cAMP/MPA or were left undifferentiated. Cells were seeded in culture slides, and the next day, AC-1M88 spheroids were placed onto these monolayers and cocultured for 2 days. In parallel, T-HESC cells were transfected, decidualized, and replated according to the same time scheme but without addition of spheroid for immunoblot analysis (Fig. 3A) . This confirmed that CD82 was induced by 5 days of decidualizing treatment and remained elevated even though the decidualizing stimulus had been omitted during the following 3 days. Induction of CD82 was completely suppressed by si-CD82, and silencing persisted throughout the entire 9-day culture period (Fig. 3B) . Spheroids expanded significantly more if the T-HESC had been decidualized with cAMP or cAMP/MPA compared to nondecidualized cells. However, silencing of CD82 had no effect on spheroid expansion (Fig. 3C) . Likewise, silencing of CD82 in decidualized T-HESC did not affect spheroid expansion when the assay was performed in the presence of HB-EGF/IL-1b/LIF or when the coculture period was extended from 2 to 3 days (Fig. 3D) .
Silencing of CEACAM1 Does Not Affect the Chemotactic Response of AC-1M88 Cells to Factor Cocktail or T-HESC Secretions
The expansion of trophoblast spheroids involves locomotion of trophoblast cells on the underlying T-HESC monolayer. We wondered whether AC-1M88 cells would also migrate in response to soluble T-HESC signals. Chemotaxis was assessed in transwell migration assays by seeding a T-HESC monolayer (nondecidualized or decidualized) in the lower compartment to create a concentration gradient of T-HESC derived secretory products acting on AC-1M88 cells plated in the upper compartment (Fig. 4A) . AC-1M88 cells mounted a strong chemotactic response toward cocultured T-HESC regardless of the decidualization status of the latter. The factor cocktail HB-EGF/IL-1b/LIF caused equally pronounced chemotaxis (Fig.  4A) . Next, we assessed the requirement of CEACAM1 in the chemotactic response by silencing its expression in AC-1M88 cells (Fig. 4B) . Silencing was confirmed by Western blot analysis (Fig. 4C) . However, the basal migratory activity of AC-1M88 cells or the marked chemotactic responses to factor cocktail or T-HESC secretory signals were not altered by CEACAM1 depletion (Fig. 4B) .
Silencing of CD82 Inhibits the Chemotactic Response of T-HESC to Factor Cocktail or AC-1M88 Secretions
We reported previously that primary hESCs and the telomerase-immortalized hESC line St-T1b show considerable migratory activity in response to trophoblast-derived signals [6] . Here we aimed at recapitulating these observations with the T-HESC line and extended the study to include the factor combination HB-EGF/IL-1b/LIF as a putative chemotactic stimulus in transwell migration assays. Migration of decidualized T-HESC was stimulated by HB-EGF/IL-1b/LIF and by the presence of AC-1M88 cells cocultured in the lower compartment (Fig. 5A ). In parallel with the migration assay, decidualized T-HESC in monolayer culture were treated with Top) Spheroids formed from AC-1M88 cells were placed on a monolayer of undifferentiated T-HESC in the absence or presence of IL-1b (10 ng/ml), LIF (10 ng/ml), or HB-EGF (20 ng/ml) alone or in combination. The extent of spheroid expansion was assessed on d3 and expressed relative to the area of spheroids on d0 (means 6 SD of six to eight replicate wells). *P , 0.05, **P , 0.01, and ***P , 0.001 compared to unstimulated control (open bar). Bottom) Protein extracts of AC-1M88 cells, treated for 3 days with the factors indicated above, were analyzed by Western blotting for CEACAM1 and the loading control GAPDH.
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HB-EGF/IL-1b/LIF or with conditioned medium from AC-1M88 cells for immunoblot analysis. CD82 protein levels were elevated in response to HB-EGF/IL-1b/LIF treatment, while AC-1M88 supernatant had no effect (Fig. 5B) . Next, we investigated the role of CD82 in chemotactic migration by silencing its expression in decidualized T-HESC. CD82 depletion resulted in pronounced reduction of chemotaxis toward HB-EGF/IL-1b/LIF or AC-1M88 conditioned medium (Fig. 5C ). Immunoblot control confirmed elevation of CD82 protein by HB-EGF/IL-1b/LIF and abrogation of protein expression on si-CD82 transfection (Fig. 5D ).
EGFR Signaling in T-HESC Is Not Impaired by CD82 Depletion
It has been reported that depletion of CD82 in HeLa cells leads to enhanced endocytosis of activated EGFR and impaired mitogen-activated protein kinase (MAPK) signaling [34] . At first, we compared EGFR levels in nondecidualized and decidualized T-HESC and observed an increase in receptor expression with decidualization, along with increased CD82 protein. Knockdown of CD82 did not alter EGFR levels in either population (Fig. 6A) . HER4 was not detectable in T-HESC cells (data not shown; two different antibodies were employed that effectively detected HER4 in the breast cancer cell line T47D, used as a positive control). Negative controltransfected or si-CD82-transfected T-HESC were stimulated with HB-EGF/IL-1b/LIF for 5, 10, or 30 min and then analyzed for activation of the MAPK isoforms ERK1 and ERK2 (Fig. 6B) . At all time points, ERK1/2 phosphorylation was stimulated by the factor cocktail, whereas the basal level of activated ERK1/2 slightly decreased with time. No difference in the response was seen between nondecidualized and decidualized cells or on silencing of CD82. EGFR activation was signified by the appearance of lower-mobility EGFR species on the immunoblot, likely reflecting ligand-induced phosphorylation of the receptor. Taken together, the abrogation of the chemotactic response to HB-EGF/IL-1b/LIF on CD82 depletion cannot be explained by a reduction in EGFR expression or impaired ERK1/2 signaling.
Silencing of CD82 Has No Effect on the Chemokinetic Activity of T-HESC
In the above transwell migration assays, directional chemotactic responses to stimuli in a concentration gradient had been assessed. We next wished to investigate chemokinesis, that is, random motile activity elicited by a uniformly present stimulus. This was studied in a modified wound healing assay (Fig. 7) . The factor cocktail HB-EGF/IL-1b/LIF Figure 1 . Spheroid expansion on d3 was expressed relative to d0 (means 6 SD of eight replicate wells). Stimulation by factor cocktail was significantly different from unstimulated controls under every condition (P , 0.001). Letters indicate that values were significantly different from each other (P , 0.001). **P , 0.01 and ***P , 0.001 between si-neg and si-CEACAM1 transfected spheroids. B) Protein extracts from spheroids transfected and stimulated as above were analyzed by Western blotting for CEACAM1, EGFR, and GAPDH.
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significantly stimulated chemokinesis, whereas trophoblast conditioned medium was without effect. This was in marked contrast to the robust chemoattractant activity of trophoblast conditioned medium as described above. Silencing of CD82 did not alter chemokinetic motility in the absence or presence of stimuli.
Proteome Profiling of T-HESC and AC-1M88 Secretions
In order to identify candidate chemotactic factors in the communication between endometrial stromal and trophoblast cells, conditioned media from T-HESC (undifferentiated or decidualized) and AC-1M88 cells were subjected to proteome profiling for cytokines and angiogenesis factors (Table 1) . Overall, T-HESC produced a richer array of such factors than did AC-1M88 cells. Highly expressed by all cell populations were macrophage migration inhibitory factor (MIF), plasminogen activator inhibitor-1 (PAI-1), tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), and vascular endothelial growth factor (VEGF). Hepatocyte growth factor (HGF) was produced by both undifferentiated and decidualized T-HESC.
Decidualization of T-HESC was signified by the appearance of typical products like PRL, C-X-C motif chemokine 1 (CXCL1; also known as growth-regulated alpha protein, GROa), activin-A, or IL-6. Although IGFBP-1 is another classical decidualization marker, its level of detection was high in both undifferentiated and decidualized T-HESC supernatants. By ELISA, however, we measured very low levels of IGFBP-1 in the supernatants of nondecidualized cells but a vast increase after decidualizing treatment (Supplemental Fig. S1 ). This suggests that detection of IGFBP-1 by the proteome profiler array was saturating even at low concentrations. On the other hand, the level of PRL in undifferentiated cells was below the limit of detection both by proteome profiling and by ELISA and distinctly elevated on decidualizing treatment (Table 1 and Supplemental Fig. S1 ). Decidualization-associated increases were also seen for amphiregulin, C-C motif chemokine 2 (CCL2; also known as monocyte chemotactic protein 1, MCP-1), macrophage colony-stimulating factors CSF-2 and CSF-3, IGFBP-2, and the matrix metalloproteinases MMP-8 and -neg) or si-RNA directed to CD82 (si-CD82) and then left undifferentiated or induced to decidualize for 5 days with 8-Br-cAMP alone or 8-Br-cAMP/MPA. Cells were replated and maintained for another 3 days in the absence of decidualizing stimulus before protein extracts were harvested. b) For spheroid expansion assays, T-HESC were transfected and stimulated as above, but 1 day after replating, spheroids were added and cocultured for another 2 days. B) Protein extracts were harvested according to scheme a and subjected to immunoblot analysis for CD82 and GAPDH. C) According to scheme b, AC-1M88 trophoblast spheroids were plated on monolayers of T-HESC that had been transfected with si-neg or si-CD82 and then induced to decidualize (D) with 8-Br-cAMP (gray bars) or 8-Br-cAMP/MPA (black bars) or left undifferentiated (ND; open bars). The extent of spheroid expansion after 2 days of coculture was quantified and expressed relative to spheroid sizes at d0 (means 6 SD of six to eight replicate wells). ***P , 0.001; no significant differences were seen between si-neg and si-CD82 treatments. D) AC-1M88 trophoblast spheroids were plated on monolayers of T-HESC that had been transfected with si-neg or si-CD82 and induced to decidualize (D) with 8-BrcAMP/MPA for 5 days. Cocultures were allowed to proceed for 2 or 3 days in the absence or presence of HB-EGF/IL-1b/LIF. The extent of spheroid expansion was quantified and expressed relative to spheroid sizes at d0 (means 6 SD of seven or eight replicate wells). ***P , 0.001; no significant differences were seen between si-neg and si-CD82 cultures.
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MMP-9. Two factors were identified as specific to AC-1M88 cells: placenta growth factor (PlGF) and PDGF-AA.
Chemotactic Potential of Factors Detected by Proteome Profiling: Trophoblast-Expressed PDGF-AA Is a Chemoattractant for T-HESC
While proteome profiling had revealed the presence of HGF in both undifferentiated and decidualized T-HESC, IL-6 had been detected as specific for decidualized cells. In a transwell migration assay, both stromal cell products were tested for their effect on trophoblast cells. IL-6 did not stimulate chemotaxis of AC-1M88 cells, while HGF elicited a small response (Supplemental Fig. S2) .
Conversely, trophoblast-specific factors PlGF and PDGF-AA were assessed for their chemoattractant effect on T-HESC. While PlGF elicited no migratory response (data not shown), PDGF-AA modestly stimulated chemotaxis of decidualized T-HESC (Fig. 8A) . Addition of a neutralizing antibody to PDGF significantly reduced the chemoattractant activity of trophoblast conditioned medium, supporting the notion that PDGF-AA is one of the active trophoblast components stimulating T-HESC chemotaxis (Fig. 8A) . Notably, silencing of CD82 diminished chemotaxis toward PDGF-AA (Fig. 8B) . This experiment furthermore demonstrated that chemotaxis is also triggered by HB-EGF alone, and this again was inhibited by CD82 depletion (Fig. 8B ).
DISCUSSION
Our study sheds new light on the communication between decidualizing endometrial stromal cells and trophoblast. We demonstrate a mutual stimulation of chemotactic migration between AC-1M88 trophoblast cells and T-HESC endometrial stromal cells and demonstrate a promigratory role for the cell surface molecules CEACAM1 and CD82.
In the pregnant uterus, the decidual compartment produces a wide array of soluble factors that can either promote or inhibit trophoblast motility [35] . Positive regulators include HB-EGF, IL-1b, and LIF, which we investigated in the present study. A distinct proinvasive function of IL-1b has previously been demonstrated in primary trophoblast cell systems. IL-1b stimulated outgrowth from villous explant cultures on collagen and migration of primary EVT through fibronectin-coated inserts [36] . LIF promotes migration of the HTR-8/SVneo trophoblast cell line via induction of prostaglandin E 2 production, an effect that is enhanced by IL-1b [37] . HB-EGF stimulates transwell migration of HTR-8/SVneo cells via activation of ERK1/2, p38, and AKT signaling [38] . Multiple lines of evidence point toward a network between HB-EGF, IL-1b, and LIF signaling pathways. Both HB-EGF and IL-1b induce LIF expression in endometrial epithelial cells [39, 40] . 
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Migration induced by IL-1b in a small cell lung cancer cell line involves cross talk with EGFR signaling. IL-1b stimulates MMP-9 activity and proteolytic cleavage of the transmembrane precursor of HB-EGF (tm-HB-EGF) and thus the shedding of mature HB-EGF, resulting in EGFR activation [41] . None of these three factors has previously been tested on endometrial stromal cells in the context of motility.
In our present study, we show that the triple-factor combination HB-EGF/IL-1b/LIF is a strong chemoattractant for both endometrial stromal and trophoblast cells and that it promotes trophoblast spheroid expansion on an endometrial stromal cell monolayer. IL-1b or HB-EGF alone or in combination with LIF stimulated trophoblast spheroid expansion to the same extent as did the triple combination. On the other hand, the triple combination up-regulated CEACAM1 protein in AC-1M88 cells much more strongly than did any of the factors alone or in dual combination, with HB-EGF being the most effective component. In sum, there was no direct correlation between the extent of CEACAM1 induction and the promotion of spheroid expansion. Yet silencing of CEACAM1 inhibited spheroid expansion on T-HESC monolayer in response to HB-EGF/IL-1b/LIF. In nontransfected or controltransfected cells, EGFR levels were down-regulated on treatment with HB-EGF/IL-1b/LIF, an observation consistent with the well-characterized lysosomal degradation of EGFR induced by HB-EGF but not other EGFR ligands, such as EGF Activin- 
ROLE OF CD82 AND CEACAM1 IN IMPLANTATION
or amphiregulin [42] . Notably, HB-EGF-mediated EGFR down-regulation was not seen in spheroids of si-CEACAM1 transfected AC-1M88 cells, indicating altered EGFR trafficking, processing, and/or signaling on CEACAM1 knockdown.
Little is known about a functional link between CEACAM1 and EGFR. One study demonstrated that CEACAM1, when overexpressed, is a direct substrate of the EGFR tyrosine kinase activity triggered by EGF binding. Phosphorylated CEACAM1 binds and sequesters the Shc adapter protein, thus uncoupling EGFR from the ERK1/2 MAPK pathway, resulting in downregulation of the mitogenic activity of EGF [43] . It remains to be determined if and how lack of CEACAM1, inversely, interferes with EGFR activation.
CEACAM1 has been classified as a tumor suppressor because its expression is frequently down-regulated in human malignancies. Paradoxically, it appears to cofunction as a metastasis promoter by enhancing invasiveness [44] . In early pregnancy placenta, CEACAM1 is detected in invasive EVT at the implantation site but not in villous cytotrophoblast or syncytiotrophoblast. Cultured EVT with invasive phenotype are also positive for CEACAM1 [26] . In the AC-1M88 trophoblast cell line, CEACAM1 overexpression has been shown to enhance migration and invasiveness [27, 45] . Recently, an interactome of human implantation has been deduced from genome expression analyses of human embryos and receptive state endometrium. Among the newly identified interactors was CEACAM1, engaged in networks with annexin A2 or paxillin [46] . Our findings support a role of CEACAM1 in implantation, as knockdown of its expression resulted in reduced spreading of trophoblast spheroids on a monolayer of decidualized T-HESC in response to HB-EGF/IL-1b/LIF. The function of CEACAM1 in this context is most likely based on heterotypic cell-cell interactions with endometrial cells or with the extracellular matrix (ECM) deposited by them because no inhibitory effect of CEACAM1 silencing was seen when AC-1M88 spheroids were exposed to the factor cocktail on cell culture surface in the absence of an endometrial monolayer. Overexpression of CEACAM1 in endothelial cells has been reported to increase motility and wound healing but only on specific substrates [47] . The effect was apparent on laminin-1 but not on fibronectin and was mediated by integrin-dependent signaling. Laminin expression is up-regulated on in vitro decidualization of hESCs [48] , and in vivo, laminins are major constituents of the decidual cell basement membrane implicated in trophoblast attachment and outgrowth [49, 50] . Knockdown of CEACAM1 in our coculture system may thus impair integrin-dependent interaction between trophoblast and laminin-positive endometrial stromal cells.
In contrast, the chemotactic response of AC-1M88 cells to soluble factors was not affected by silencing of CEACAM1, underpinning the notion that CEACAM1 engages in direct cellcell or cell-ECM interactions.
The metastasis suppressor function of CD82 has been attributed to diverse mechanisms, the majority of these being based on lateral interactions of CD82 with other membrane proteins, such as integrins, EGFR, or the HGF receptor protooncogene c-Met [51] [52] [53] . These interactions negatively impact proliferation and migration of CD82 expressing cells. The underlying mechanisms have been investigated largely by reintroducing the tetraspanin into CD82-deficient cancer cell lines [54] . Overexpression in prostate cancer cells was found to interfere with the activation of integrin b1 at the cell surface and resulted in reduced migration and invasion [21, 55] . Both integrin-mediated activation of the proto-oncogene tyrosineprotein kinase Src and HGF-mediated activation of its receptor c-Met are suppressed on reintroduction of CD82 into highly invasive metastatic prostate cancer cells [22] . Transfected CD82 in multiple myeloma cells reduces not only invasive potential but also survival [56] . Restoration of CD82 expression in ovarian cancer cells results in stronger adhesion to and reduced migration on vitronectin, mediated by interaction of CD82 with integrin av/b3 [51] . In all these studies, CD82 was overexpressed and likely present at supranormal levels, which may skew the outcome.
We took an alternative approach to studying the role of CD82 in migration. Human endometrial stromal cells express very low levels of CD82 in the undifferentiated, proliferative stage. On decidualizing treatment over several days, CD82 levels increase, and this is largely due to an increase in the protein level without a corresponding induction of the encoding transcript [17] . The up-regulation of CD82 is likewise seen in vivo in the secretory phase endometrium and the decidua of early pregnancy [17] . Our in vitro model of decidualization therefore properly reflects changes of the amount of CD82 within a supposedly physiological range. Notably, our attempts to establish endometrial stromal cell lines stably overexpressing CD82 failed, most likely due to the proapoptotic effect of overexpression of this tetraspanin (unpublished observations). In addition to the delayed upregulation of CD82 protein with decidualization, CD82 is rapidly induced by IL-1b at the transcriptional level [7, 17, 57] . By decidualization and/or treatment with a cocktail containing IL-1b, we could thus elevate endogenous CD82 protein without driving the endometrial stromal cells into apoptosis and could then manipulate the CD82 level by RNA interference.
Contrary to expectation, our approach revealed a promigratory role of CD82. CD82 knockdown in decidualized T-HESC markedly reduced their chemotactic response to HB-EGF or HB-EGF/IL-1b/LIF. We therefore reasoned that silencing of CD82 might interfere with EGFR signal transduction. CD82 has been shown to directly associate with EGFR in epithelial cells, and overexpression of CD82 results in enhanced receptor endocytosis and desensitization of EGFinduced signaling [20] . On the other hand, CD82 silencing in HeLa cells promotes clathrin-dependent endocytosis of EGFR in response to EGF and diminishes EGF-mediated ERK phosphorylation within 5 min [34] . In our system, EGFR levels were increased on decidualizing treatment of T-HESC but not altered as a consequence of CD82 silencing. Treatment of nondecidualized or decidualized T-HESC with factor cocktail containing HB-EGF caused rapid phosphorylation of ERK within 5 min, an effect sustained for at least 30 min and concurring with phosphorylation of EGFR. The signaling response was seen regardless of CD82 silencing, arguing against perturbation of ERK signaling.
The authors of a recent study suggested that CD82 expression on decidual stromal cells (DSCs) is inhibitory to trophoblast invasion [58] . Technically, DSC were cocultured with BeWo trophoblast cells on the upper surface of a transwell invasion insert. Cells having migrated to the lower surface were stained histochemically and counted under the assumption that exclusively trophoblastic cells would have invaded. On silencing of CD82 in the DSCs, the number of invaded cells strongly increased, which was interpreted as enhanced invasion of cocultured trophoblast [58] . We had previously used a similar coinvasion assay of decidualized hESCs mixed with AC-1M88 cells but had stained invaded cells at the lower surface by dual immunohistochemistry to discriminate the two cell types. This revealed that a prominent proportion of invaded cells were in fact hESCs [6] . It would therefore be of high interest to reevaluate the data of the aforementioned study and GELLERSEN ET AL.
determine if CD82 depletion in DSCs rather had promoted invasiveness of DSCs and not or not only of cocultured BeWo trophoblast.
The same group performed transwell invasion assays by plating primary trophoblast cells in the upper and DSCs in the lower compartment [59] . Trophoblast invasiveness was found to increase when CD82 had been silenced in the DSC monolayer. The underlying mechanism remained unclear, but again an anti-invasive function toward trophoblast cells was ascribed to decidual CD82. Finally, this group implicated CD82 in the etiology of endometriosis. Based on the observation that CD82 levels were lower in endometriotic compared to normal hESCs, CD82 was assumed to be antiinvasive. Silencing of CD82 in eutopic hESCs increased their invasive potential concurrently with an up-regulation of integrin b1 and a down-regulation TIMP-1 and TIMP-2 [25] . We could not recapitulate these findings. While we observed an increase of integrin b1 with decidualization, there was no change on CD82 silencing (data not shown). Most important, we collected compelling evidence that CD82 in endometrial stromal cells supports migration. The massive induction of CD82 on decidualization and in the presence of IL-1b did not negate the motile potential of the cells. CD82 silencing markedly blunted chemotaxis toward trophoblast-conditioned medium, factor cocktail, HB-EGF, and PDGF-AA, indicating a general requirement for CD82 in facilitating endometrial stromal cell migration.
While chemotaxis of T-HESC was diminished by si-CD82, the chemokinetic response was not affected. Different signaling pathways control directed migration in a gradient (chemotaxis) versus random motility in a uniform signal (chemokinesis). In primary hESCs and the endometrial stromal cell line St-T1b, we found an involvement of ERK1/2, p38, and phosphoinositide 3-kinase (PI3K)/AKT signaling in chemotaxis, whereas chemokinesis depended primarily on PI3K/AKT activation [60] . The latter signaling pathway thus does not appear to be perturbed by CD82 silencing, or other, as-yet-unidentified compensatory pathways are activated by the factor cocktail. Implantation of a blastocyst or expansion of trophoblast spheroid on endometrial stromal cells depends on motility of the stromal cells that align around the implanting entity. This is facilitated by inhibition of ROCK signaling, which promotes chemokinesis [3, 4, 7, 60] . Of note, CD82 silencing in T-HESC inhibited neither chemokinesis nor expansion of cocultured trophoblast spheroid in our present study, suggesting that CD82 mediates chemotactic attraction to the implantation site rather than random motility in the immediate vicinity.
By proteome profiling for cytokines and angiogenesis factors, we identified PlGF and PDGF-AA as trophoblast products. PlGF is a member of the VEGF family and binds to the VEGFR1 receptor [61] . Although it has been characterized as a chemoattractant for various cell types [62, 63] , it did not exhibit such activity on T-HESC in our study. On the other hand, PDGF-AA elicited a chemotactic response in T-HESC, and by the use of a neutralizing antibody, we could demonstrate that PDGF-AA is a chemoattractive constituent of trophoblast-conditioned medium. This observation may have implications in the earliest stages of blastocyst implantation because PDGF-AA expression has been identified in the trophectoderm of Day 5 implantation competent blastocysts, while the corresponding receptor PDGFRa is expressed by the receptive endometrium [64] .
The impact of primary trophoblast supernatant on endometrial stromal cell gene expression has been assessed by gene expression profiling [65] . Among the most highly up-regulated endometrial genes in response to trophoblast supernatant were IL6 and CXCL1. Notably, we detected IL-6 and CXCL1 as proteins highly induced on decidualization in T-HESC. In essence, trophoblast signals are likely to enhance the decidualizing reaction of the stromal compartment and support a feed-forward loop to promote the dynamic interactions at the invasion front.
Conversely, effects of decidualized endometrial stromal cell-derived factors on trophoblast invasiveness and on the profile of invasive trophoblast membrane and secreted proteins have been described, implying a role for decidual cells in regulation of implantation and placentation [66, 67] . Our findings further strengthen the concept that decidualizing FIG. 8 . Chemotactic response of T-HESC to PDGF-AA and effect of CD82 silencing. A) Decidualized T-HESC were subjected to transwell migration assay with PDGF-AA or AC-1M88 conditioned medium (CM) in the lower compartment in the absence or presence of a neutralizing antibody to PDGF (pan). Results are expressed as motility index (means 6 SD of triplicate wells).
a P , 0.05 compared to untreated control (open bar); b P , 0.001 compared to untreated control. ***P , 0.001; **P , 0.01. B) T-HESC were transfected with si-neg or si-CD82 and then induced to decidualize for 5 days. Chemotaxis was assessed in response to PDGF-AA or HB-EGF. Letters indicate that values were significantly different from each other (P , 0.001). ***P , 0.001 between si-neg and si-CD82 treatments.
endometrial stromal cells enhance trophoblast migration. While it was beyond the scope of the present study to test all candidate chemoattractants identified by proteome profiling of T-HESC supernatants, HGF may be one of the stromal products stimulating trophoblast migration.
While we did not detect HB-EGF in the supernatant of the T-HESC line, there is ample evidence that the growth factor is produced by primary hESCs [39] . In vitro decidualization of primary hESCs leads to increased production of both tm-HB-EGF and soluble HB-EGF. The latter promotes further decidualization and survival of the hESCs [15] . Decidualizing hESCs have been shown to respond to cocultured developmentally impaired human blastocysts by reduced secretion of HB-EGF and IL-1b. This does not occur in the presence of normal blastocysts and underscores the concept of decidualized stromal cells serving as biosensors for embryo quality [68] . The quality control mechanism might be based partly on motile processes, as migration of hESCs from fertile control women toward low-quality embryos was reportedly inhibited compared to migration in the presence of high-quality embryos [69] . Notably, hESCs isolated from women with recurrent pregnancy loss failed to discriminate between high-and lowquality embryos in their migratory response [69] . It has also been shown that recurrent pregnancy loss coincides with impaired decidualization of hESCs in these subjects, perturbing embryo-maternal interactions [70] . It will be of interest to investigate whether hESCs from such patients also display abnormal regulation of CD82 on decidualization, possibly contributing to the disorder.
A mutual stimulation of motility between decidualizing endometrial stromal and trophoblast cells renders further support to our hypothesis that not only invasiveness of trophoblast but also motility of decidualizing endometrial stromal cells contributes to tissue remodeling on blastocyst implantation and formation of the placenta. PDGF-AA was identified as a novel trophoblast-derived chemoattractant for endometrial stromal cells. CD82 and CEACAM1 are cell surface molecules that we demonstrate here to participate in promoting migration in response to soluble and matrixdependent triggers in endometrial stromal and trophoblast cells, respectively.
